Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your experience. Save up to 40% More details

Abbott Laboratories BDR (ABTT34)

Create Alert
Create Alert
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile






Delivery Method


Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
171.84 +0.84    +0.49%
21/01 - Closed. Currency in BRL ( Disclaimer )
Type:  Equity
Market:  Brazil
  • Volume: 36
  • Bid/Ask: 171.54 / 171.84
  • Day's Range: 170.00 - 171.84
Abbott Laboratories BDR 171.84 +0.84 +0.49%
Period Ending: 2021
Total Current Assets 23492 22627 21817 20441
Cash and Short Term Investments 9692 8944 8372 7148
Cash - - - -
Cash & Equivalents 9302 8658 8054 6838
Short Term Investments 390 286 318 310
Total Receivables, Net 6405 6113 6096 6414
Accounts Receivables - Trade, Net 6405 6113 6096 6414
Total Inventory 5261 5439 5387 5012
Prepaid Expenses 2134 2131 1962 1867
Other Current Assets, Total - - - -
Total Assets 73795 73269 72785 72548
Property/Plant/Equipment, Total - Net 8831 8816 8832 9029
Property/Plant/Equipment, Total - Gross 19182 19074 18697 18793
Accumulated Depreciation, Total -10351 -10258 -9865 -9764
Goodwill, Net 23299 23485 23384 23744
Intangibles, Net 13312 13681 14181 14784
Long Term Investments 812 805 832 821
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 4049 3855 3739 3729
Other Assets, Total - - - -
Total Current Liabilities 12867 12614 12462 11907
Accounts Payable 4017 4017 4066 3946
Payable/Accrued - - - -
Accrued Expenses 6734 6602 6364 6581
Notes Payable/Short Term Debt 197 199 199 213
Current Port. of LT Debt/Capital Leases 754 755 756 7
Other Current liabilities, Total 1165 1041 1077 1160
Total Liabilities 39373 39469 39223 39764
Total Long Term Debt 17446 17547 17489 18527
Long Term Debt 17446 17547 17489 18527
Capital Lease Obligations - - - -
Deferred Income Tax - - - -
Minority Interest 216 229 226 219
Other Liabilities, Total 8844 9079 9046 9111
Total Equity 34422 33800 33562 32784
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 24285 24153 24023 24145
Additional Paid-In Capital - - - -
Retained Earnings (Accumulated Deficit) 30376 29053 28669 27627
Treasury Stock - Common -10999 -10340 -9845 -10042
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total -9240 -9066 -9285 -8946
Total Liabilities & Shareholders' Equity 73795 73269 72785 72548
Total Common Shares Outstanding 1768.29 1772.82 1776.82 1771.23
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at’s discretion.

ABTT34 Comments

Write your thoughts about Abbott Laboratories BDR
Are you sure you want to delete this chart?
Post also to:
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Are you sure you want to delete this chart?
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
Sign up with Email